Company Profile
Veeva Stock Price, News & Analysis
- Ticker:
- VEEV
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- United States
Stock performance
217.80 USD (+2.01%)
Close
Last updated: August 6, 2026
29.9B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, VEEV closed up 2.01% at $217.80. No new same-company headline was identified in the current news window.
Company overview
Business overview
Veeva Systems is a cloud software company built specifically for the life sciences industry. Its core products support commercial, clinical, regulatory, and data workflows for pharma and biotech customers, making it a key infrastructure name rather than a therapeutic developer.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, Veeva has a global footprint across life sciences companies. It sits in enterprise software and life sciences technology, not biotechnology proper.
Business Model Characteristics
The business relies on recurring software subscriptions, customer retention, and cross-sell across commercial and development workflows. Investors tend to watch subscription growth, operating margin, product expansion, and the strength of the broader life sciences spending environment.
Position Within the Biotechnology Landscape
Veeva is one of the most important software platforms in the biotech ecosystem. It is not a drug stock, but it matters because it helps power commercial and clinical operations across the sector.
Future catalysts
Veeva’s catalysts are Vault CRM adoption, clinical-data-cloud traction, and continued penetration of regulated-life-science software. That readout matters because it decides whether the asset is ready for a larger and more expensive development step. If the data come in cleanly, the market tends to give the broader platform behind the program more credit.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Veeva (VEEV)?
Veeva (VEEV) most recently closed at 217.80 USD, a +2.01% move versus the previous session.
What is the market cap of Veeva (VEEV)?
Veeva currently has a market capitalization of 29.9B USD on BioPharmSignal.
What does Veeva do?
Veeva Systems is a cloud software company built specifically for the life sciences industry. Its core products support commercial, clinical, regulatory, and data workflows for pharma and biotech customers, making it a key infrastructure name rather than a therapeutic developer.
On which exchange is VEEV stock listed?
Veeva (VEEV) is associated with NYSE, United States, Biopharma.
What is Veeva?
Veeva’s catalysts are Vault CRM adoption, clinical-data-cloud traction, and continued penetration of regulated-life-science software.
Which conditions is Veeva targeting with Veeva?
Veeva’s catalysts are Vault CRM adoption, clinical-data-cloud traction, and continued penetration of regulated-life-science software.
How does Veeva describe recent progress with Veeva?
Veeva’s catalysts are Vault CRM adoption, clinical-data-cloud traction, and continued penetration of regulated-life-science software.
What is Systems?
Veeva Systems is a cloud software company built specifically for the life sciences industry.